4-TCPA is a potent inhibitor of VEGFR2. It induces apoptosis and causes cell cycle arrest, potentially by inhibiting VEGFR2 and EGFR signaling, while also affecting the mTOR pathway. Furthermore, 4-TCPA suppresses the viability and proliferation of various cancer cell lines. It is applicable in research on cancers such as lung cancer, breast cancer, and leukemia.
Target-Kategorie:
Apoptosis|||VEGFR|||mTOR|||EGFR
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
